WASHINGTON--(BUSINESS WIRE)--The following statement may be attributed to Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood:
“BIO extends our congratulations to Dr. Califf on his confirmation as Commissioner of the FDA, a job that carries tremendous responsibility in protecting public health and advancing biotechnology innovation. Dr. Califf’s confirmation comes at a time of tremendous advances being made in biotechnology and regulatory science, and I am confident that he will provide the stability, leadership and confidence the public seeks from an agency entrusted with such a critical mission.
“We applaud Chairman Alexander and Ranking Member Murray for their bi-partisan leadership and cooperation throughout Dr. Califf’s confirmation process. We look forward to working with Dr. Califf to ensure that the FDA’s regulatory capabilities and science continue to keep pace with the tremendous progress taking place in biotechnology innovation.”
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
Upcoming BIO Events
|
BIO
International Convention |
13th
Annual BIO Asia International Conference |
|||
|
World
Congress on Industrial Biotechnology |
BIO-Europe
Spring |
